Singular Genomics Systems Stock Price on November 25, 2024
| OMIC Stock | USD 21.90 0.53 2.48% |
If you're considering investing in Singular Stock, it is important to understand the factors that can impact its price. As of today, the current price of Singular Genomics stands at 21.90, as last reported on the 26th of November, with the highest price reaching 21.90 and the lowest price hitting 21.03 during the day. Singular Genomics is very risky given 3 months investment horizon. Singular Genomics Systems owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.85% are justified by taking the suggested risk. Use Singular Genomics Systems Semi Deviation of 2.98, risk adjusted performance of 0.1329, and Coefficient Of Variation of 619.44 to evaluate company specific risk that cannot be diversified away.
As of November 26, 2024, Total Stockholder Equity is expected to decline to about 153.8 M. In addition to that, Common Stock Total Equity is expected to decline to 4,400. At present, Singular Genomics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 0.20, whereas Price To Sales Ratio is forecasted to decline to 10.93. Singular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Singular |
Sharpe Ratio = 0.1618
| Best Portfolio | Best Equity | |||
| Good Returns | OMIC | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.85 actual daily | 56 56% of assets have lower returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Singular Genomics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Singular Genomics by adding it to a well-diversified portfolio.
Price Book 0.4355 | Enterprise Value Ebitda 0.7749 | Price Sales 19.7124 | Shares Float 1.4 M | Wall Street Target Price 12.45 |
Singular Genomics Valuation on November 25, 2024
It is possible to determine the worth of Singular Genomics on a given historical date. On November 25, 2024 Singular was worth 21.51 at the beginning of the trading date compared to the closed value of 21.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Singular Genomics stock. Still, in general, we apply an absolute valuation method to find Singular Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Singular Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Singular Genomics' related companies.
| Open | High | Low | Close | Volume | |
| 21.40 | 22.15 | 21.24 | 21.42 | 10,614 | |
11/25/2024 | 21.51 | 21.75 | 21.00 | 21.37 | 24,028 |
| 21.31 | 21.90 | 21.03 | 21.90 | 6,410 |
| Backtest Singular Genomics | | | Singular Genomics History | | | Singular Genomics Valuation | Previous | Next |
Singular Genomics Trading Date Momentum on November 25, 2024
| On November 26 2024 Singular Genomics Systems was traded for 21.90 at the closing time. The top price for the day was 21.90 and the lowest listed price was 21.03 . The trading volume for the day was 6.4 K. The trading history from November 26, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.48% . The trading price change against the current closing price is 0.28% . |
Singular Genomics Systems Fundamentals Correlations and Trends
By evaluating Singular Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Singular Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Singular financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Singular Genomics Stock history
Singular Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Singular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Singular Genomics Systems will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Singular Genomics stock prices may prove useful in developing a viable investing in Singular Genomics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.4 M | 2.3 M | |
| Net Loss | -81.8 M | -85.9 M |
Singular Genomics Quarterly Net Working Capital |
|
Singular Genomics Stock Technical Analysis
Singular Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Singular Genomics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Singular Genomics Systems cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Singular Genomics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Singular Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Singular Genomics shares will generate the highest return on investment. By undertsting and applying Singular Genomics stock market strength indicators, traders can identify Singular Genomics Systems entry and exit signals to maximize returns
Singular Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Singular Genomics' price direction in advance. Along with the technical and fundamental analysis of Singular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Singular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1329 | |||
| Jensen Alpha | 2.71 | |||
| Total Risk Alpha | 0.0981 | |||
| Sortino Ratio | 0.6322 | |||
| Treynor Ratio | 3.79 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Singular Stock analysis
When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |